Hosted on MSN

MicroPort NeuroTech’s Promising Stent Trial: A Potential Game-Changer in Cerebral Artery Treatment

MicroPort NeuroTech Limited ((HK:2172)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert ...
ahajournals.org

Abstract 4341368: Hepatic Retinol-Binding Protein 4 Mediates the Exacerbation of Myocardial I/R Injury in MAFLD mice through Augmented Oxidative Stress and Ferroptosis

Background: Metabolic dysfunction-associated fatty liver disease (MAFLD), with a global prevalence of 25%, is increasingly linked to heightened coronary artery disease (CAD) risk, accelerated CAD ...
SciELO

Anomalous origin of the left coronary artery from the pulmonary trunk. Clinical features and midterm results after surgical treatment

OBJECTIVE: To report the authors' experience with the anomalous origin of the left coronary artery (AOLCA) from the pulmonary trunk, emphasizing preoperative data, surgical aspects and midterm results ...